MTC accounts for about 3–5% of all thyroid cancers [1]. This is different from Tubular Carcinoma, where in which cancer cells retain most of the features of normal breast tissue.

Papillary thyroid cancer is a type of differentiated thyroid cancer, which means it starts in cells that make and release thyroid hormones. It typically forms in only one lobe of the thyroid gland ...

So, sporadic medullary thyroid cancer patients—the other 75%—do not have any known risk factors. [2, 3] In other words, smoking, alcohol, and environmental factors are not known to be ...

There are two types of medullary thyroid cancer: sporadic and familial. Most cases occur in younger people and are sporadic, where the cancer does not run in the family, leaving around 25% of ...

About 2160 patients with medullary thyroid cancer have been treated with vandetanib in total, of whom 565 were treated in clinical trials, but little is known about the efficacy and safety of this ...

Examples of forward-looking statements include, among others, the ability of Veracyte’s Afirma Xpression Atlas to help characterize medullary thyroid cancer, the ability of Veracyte’s Afirma ...

Vierhapper H et al. (2005) Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15: 1267–1272 ...

Veracyte, Inc. (Nasdaq: VCYT) today announced that new clinical validation data published online in Thyroid show that the company’s RNA sequencing-bas ...

Selpercatinib extended PFS compared with two approved multikinase inhibitors for treatment of RET-mutant medullary thyroid cancer, according to the agent’s manufacturer.Selpercatinib (Retevmo ...

Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [68Ga]Ga-DOTA-CCK-66 PET/CT in 2 Patients with Medullary Thyroid Cancer. Journal of Nuclear Medicine, 2023; jnumed.123.266537 DOI ...